Elucidating Genetic Variation to Power Genomic Medicine

Joined January 2023
46 Photos and videos
Every mother hopes for a healthy baby. Every family deserves answers they can trust. This #WorldHealthDay, we’re reminded how vital clarity is in genetic testing—especially during pregnancy and early life. At Constantiam, we turn uncertainty into understanding.
19
Moved into BioLabs. Still unpacking VUS. We’re excited to share that #ConstantiamBiosciences is now a proud resident at @biolabs, a space that fuels bold science, purposeful innovation, and yes, the power of RareScan’s proprietary high-throughput functional data.
21
Quarterly sync, wherever we are 🌐 From screens to the same table, our team came together for the Q2 meeting to share updates, align goals, and keep pushing the mission forward. #Constantiambiosciences #QuarterlyMeeting #PrecisionMedicine
15
Our co-founders, Norman Ong and Daniel Goldman, are at ACMG 2025. 📍Meet us at Booth 333 to learn how Constantiam Biosciences is advancing precision medicine with cutting-edge solutions for VUS resolution, rare disease diagnosis, and functional genomics. #ACMGMtg25 #ACMG2025
25
We’re heading to the Annual Clinical Genetics Meeting 25 in Los Angeles! Join us at Booth 333 to explore how our cutting-edge functional genomic platform is transforming precision medicine. RareScan™ – Advancing rare disease diagnosis with deep mutational scanning. #ACMGMtg25
18
Exciting news! We've been awarded a $2.05M Phase II SBIR grant from @NHGRI to expand our Varify™ computational engine & integrate it with MAVEvidence™, supporting clinical geneticists in improving patient care. genomeweb.com/business-news/… #ConstantiamBiosciences #NHGRI #SBIRgrant
46
ASCO's new guidelines for recommending germline testing to cancer patients: Using multigene panels for significant variants. Testing high-risk genes by cancer type (e.g., BRCA1/2 for breast cancer). Offering germline testing regardless of prior tests. bit.ly/4dRYyK3
43
Navigate the path to clarity with MAVEvidence: Where every resolved VUS accelerates our journey towards precise, personalized genetic care. Learn more constantiambio.com/platform/…
30
Transform VUS complexity into clarity with #MAVEvidence, the premier functional evidence resource. Dive into our vast database of over 186,000 pieces of evidence across 124,000 variants for precise, up-to-date insights.
42
Join Dr. Victoria Parikh in our upcoming webinar to explore how scalable assays are revolutionizing genetic testing in cardiac genetics. Discover the role of functional evidence in clarifying VUS and advancing precision medicine. Register here: bit.ly/4bC3H7t
1,194
During #MedicalGeneticsAwarenessWeek, we celebrate our partnership with the medical community in advancing genetic research. Our platform, MAVEvidence™, embodies our shared mission with #ACMG to improve health outcomes through the power of genetic insights. #ACMGMtg24
77
Constantiam Biosciences celebrates #MedicalGeneticsAwareness Week with ACMG, honoring the heroes transforming patient care through genetics. Together, we're advancing patient care, one genetic insight at a time. #ACMGMtg24 #ACMG24
1
115
Constantiam Biosciences retweeted
This #NationalHeartMonth, we highlight Dr. Victoria Parikh's insights on MAVES' vital role in cardiovascular care. Discover how genetic testing is revolutionizing the fight against heart conditions and CVDs. #HeartHealth #GeneticTesting #MAVEvidence #ConstantiamBiosciences
1
2
42
On #RareDiseaseDay2024 , we stand with 300 million people facing rare diseases. Constantiam Biosciences' MAVEvidence offers hope through genetic insights, driving forward diagnosis & treatment. Together, let's ensure no disease is too rare to care about. #MAVEvidence
41
Sometimes, even genetic variants need a little reassurance! 🧬😄 Facing an identity crisis, our VUS found comfort in the wise words of its therapist. Let's remember that every piece of our genetic puzzle has its place and purpose. #humor #VUS #genetics
31
Advancing BRCA1 gene research in #cervicalcancer with #MAVEvidence. Our tool provides crucial, updated genetic data, enhancing diagnosis accuracy and closing gaps in assessment. #CervicalCancerAwarenessMonth
91
January is #CervicalCancerAwarenessMonth. At Constantiam Biosciences, we emphasize the role of genetic testing and #MAVEvidence in understanding cervical cancer risk factors. Let's commit to advancing research and innovation in the fight against this disease.
58
Behind every great vision is a team fueled by passion and insight. Here's a glimpse into a candid moment with our Co-founders and Engineering Advisor, where discussions about #ConstantiamBiosciences' future unfold. It's these thoughtful exchanges that drive our mission forward.
1
54